By editor|Jan 12, 2009, 7:41 AM 

Goldman Sachs (GS) removed Pfizer (PFE) from its Americas Sell List, citing the underperformance of the stock relative to its peers and the potential for restructuring initiatives at the co.

Leave a Reply